Tkaczuk KHR - Search Results

1

Circulating Biomarkers in Breast Cancer.

Seale KN, Tkaczuk KHR. Seale KN, et al. Among authors: tkaczuk khr. Clin Breast Cancer. 2022 Apr;22(3):e319-e331. doi: 10.1016/j.clbc.2021.09.006. Epub 2021 Sep 22. Clin Breast Cancer. 2022. PMID: 34756687 Free article. Review.

2

Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer.

Tkaczuk KHR, Hawkins D, Yue B, Hicks D, Tait N, Serrero G. Tkaczuk KHR, et al. Clin Breast Cancer. 2020 Jun;20(3):220-227. doi: 10.1016/j.clbc.2019.11.010. Epub 2019 Dec 5. Clin Breast Cancer. 2020. PMID: 31928925 Free PMC article.

3

Neratinib in Combination With Trastuzumab for the Treatment of Patients With Advanced HER2-positive Breast Cancer: A Phase I/II Study.

Blackwell KL, Zaman K, Qin S, Tkaczuk KHR, Campone M, Hunt D, Bryce R, Goldstein LJ; 202 Study Group. Blackwell KL, et al. Among authors: tkaczuk khr. Clin Breast Cancer. 2019 Apr;19(2):97-104.e4. doi: 10.1016/j.clbc.2018.12.011. Epub 2018 Dec 20. Clin Breast Cancer. 2019. PMID: 30655172 Clinical Trial.

4

Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis.

Rice SR, Feigenberg SJ, Hamza M, Molitoris JK, Bentzen SM, Tkaczuk KHR, Rosenblatt PM, Bellavance EC, Nichols EM. Rice SR, et al. Among authors: tkaczuk khr. Breast Cancer Res Treat. 2019 Jun;175(2):473-478. doi: 10.1007/s10549-019-05150-x. Epub 2019 Feb 22. Breast Cancer Res Treat. 2019. PMID: 30796656

5

Increasing utilization of regional nodal irradiation in elderly node-positive women and declining emphasis on demographic factors.

Molitoris JK, Diwanji T, Snider JW, Bellavance EC, Kesmodel SB, Rosenblatt P, Tkaczuk K, Bentzen SM, Cohen RJ, Nichols EM, Cheston SB, Feigenberg SJ. Molitoris JK, et al. Breast Cancer Res Treat. 2017 Oct;165(3):669-676. doi: 10.1007/s10549-017-4354-x. Epub 2017 Jun 23. Breast Cancer Res Treat. 2017. PMID: 28646345

6

Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis.

Diwanji TP, Molitoris JK, Chhabra AM, Snider JW, Bentzen SM, Tkaczuk KH, Rosenblatt PY, Kesmodel SB, Bellavance EC, Cohen RJ, Cheston SB, Nichols EM, Feigenberg SJ. Diwanji TP, et al. Breast Cancer Res Treat. 2017 Sep;165(2):445-453. doi: 10.1007/s10549-017-4345-y. Epub 2017 Jun 21. Breast Cancer Res Treat. 2017. PMID: 28639030

7

Body mass and stage of breast cancer at diagnosis.

Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL. Cui Y, et al. Int J Cancer. 2002 Mar 10;98(2):279-83. doi: 10.1002/ijc.10209. Int J Cancer. 2002. PMID: 11857420 Free article.

8

A pilot study of FDG PET/CT detects a link between brown adipose tissue and breast cancer.

Cao Q, Hersl J, La H, Smith M, Jenkins J, Goloubeva O, Dilsizian V, Tkaczuk K, Chen W, Jones L. Cao Q, et al. BMC Cancer. 2014 Feb 25;14:126. doi: 10.1186/1471-2407-14-126. BMC Cancer. 2014. PMID: 24564204 Free PMC article.

9

Anti-HER2 immunoliposomes for selective delivery of electron paramagnetic resonance imaging probes to HER2-overexpressing breast tumor cells.

Burks SR, Macedo LF, Barth ED, Tkaczuk KH, Martin SS, Rosen GM, Halpern HJ, Brodie AM, Kao JP. Burks SR, et al. Breast Cancer Res Treat. 2010 Nov;124(1):121-31. doi: 10.1007/s10549-009-0715-4. Epub 2010 Jan 12. Breast Cancer Res Treat. 2010. PMID: 20066490 Free PMC article.

10

mTOR inhibitors: changing landscape of endocrine-resistant breast cancer.

Chumsri S, Sabnis G, Tkaczuk K, Brodie A. Chumsri S, et al. Future Oncol. 2014 Feb;10(3):443-56. doi: 10.2217/fon.13.178. Future Oncol. 2014. PMID: 24559450 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page